Benitec Biopharma (BNTC) Enterprise Value (2019 - 2025)
Benitec Biopharma (BNTC) posted Enterprise Value of -$188.9 million for Q4 2025, down 99.7% sequentially from -$94.6 million in Q3 2025, and down 141.11% YoY from $459.5 million in Q4 2024.
Benitec Biopharma (BNTC) Enterprise Value (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Enterprise Value for 7 years, with the latest figure at -$188.9 million in Q4 2025.
- Quarterly Enterprise Value fell 141.11% year-over-year to -$188.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$188.9 million (down 141.11% YoY) and the FY2025 annual result came in at -$97.9 million, down 92.14% from the prior year.
- Enterprise Value declined to -$188.9 million in Q4 2025 per BNTC's latest filing, from -$94.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$13000.0 in Q1 2024 and troughed at -$188.9 million in Q4 2025.
- A 5-year average of -$41.9 million and a median of -$18.1 million in 2021 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 99.8% in 2024, then tumbled 796692.31% in 2025.
- Over 5 years, Enterprise Value stood at -$12.3 million in 2021, then increased by 14.42% to -$10.6 million in 2022, then tumbled by 93.23% to -$20.4 million in 2023, then slumped by 284.27% to -$78.3 million in 2024, then plunged by 141.11% to -$188.9 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$188.9 million, -$94.6 million, and -$97.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | -188.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -188.90 Mn |
| Sep 30, 2025 | -94.59 Mn |
| Jun 30, 2025 | -97.86 Mn |
| Mar 31, 2025 | -103.58 Mn |
| Dec 31, 2024 | -78.35 Mn |
| Sep 30, 2024 | -67.86 Mn |
| Jun 30, 2024 | -50.93 Mn |
| Mar 31, 2024 | -13,000.00 |
| Dec 31, 2023 | -20.39 Mn |
| Sep 30, 2023 | -25.88 Mn |
| Jun 30, 2023 | -2.49 Mn |
| Mar 31, 2023 | -6.61 Mn |
| Dec 31, 2022 | -10.55 Mn |
| Sep 30, 2022 | -16.51 Mn |
| Jun 30, 2022 | -4.08 Mn |
| Mar 31, 2022 | -8.63 Mn |
| Dec 31, 2021 | -12.33 Mn |
| Sep 30, 2021 | -15.70 Mn |
| Jun 30, 2021 | -19.78 Mn |
| Mar 31, 2021 | -11.99 Mn |